Evolus, Inc.
EOLS
Rangering i aksjer
#12986
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Aksjekurs
$7.49
Markedsverdi
$494.72M
Endring (1 dag)
1.22%
Endring (1 år)
-48.63%
Land
US
Handel Evolus, Inc. (EOLS)
Kategori
Healthcare
Aksjeprishistorikk for Evolus, Inc. (EOLS)
Høyeste sluttskurs: $12.39 den 2025-01-01
Laveste sluttskurs: $19.84 den 2018-08-01
Laveste sluttskurs: $19.84 den 2018-08-01
Aksjeprishistorikk for Evolus, Inc. fra 2018 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2025 | 3.66% |
| 2024 | 20.62% |
| 2023 | 39.40% |
| 2022 | 15.12% |
| 2021 | -56.66% |
| 2019 | -3.72% |
| 2018 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
